Physicians Realty Trust (NYSE:DOC) has been given a $18.00 target price by stock analysts at SunTrust Banks in a report released on Monday. The firm currently has a “hold” rating on the real estate investment trust’s stock. SunTrust Banks’ price target would indicate a potential upside of 10.02% from the company’s previous close.
Several other equities research analysts also recently weighed in on the stock. Royal Bank of Canada reissued a “buy” rating and issued a $21.00 target price on shares of Physicians Realty Trust in a research note on Wednesday, November 15th. Raymond James Financial set a $20.00 target price on shares of Physicians Realty Trust and gave the company a “buy” rating in a research note on Thursday, December 7th. Cantor Fitzgerald increased their target price on shares of Physicians Realty Trust from $20.00 to $21.00 and gave the company an “overweight” rating in a research note on Tuesday, November 7th. Robert W. Baird restated an “outperform” rating and issued a $19.00 price target (down from $21.00) on shares of Physicians Realty Trust in a report on Friday, January 5th. Finally, KeyCorp upgraded shares of Physicians Realty Trust from a “sector weight” rating to an “overweight” rating in a report on Thursday, October 12th. Six analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. The company presently has a consensus rating of “Buy” and an average price target of $20.05.
Shares of Physicians Realty Trust (NYSE DOC) traded up $0.03 on Monday, hitting $16.36. 2,318,000 shares of the stock traded hands, compared to its average volume of 1,522,762. Physicians Realty Trust has a 1-year low of $16.21 and a 1-year high of $21.85. The stock has a market capitalization of $2,930.00, a P/E ratio of 71.13, a P/E/G ratio of 2.51 and a beta of 0.54. The company has a current ratio of 1.59, a quick ratio of 1.59 and a debt-to-equity ratio of 0.46.
Physicians Realty Trust (NYSE:DOC) last announced its earnings results on Friday, November 3rd. The real estate investment trust reported $0.26 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.27 by ($0.01). Physicians Realty Trust had a net margin of 11.39% and a return on equity of 1.70%. The firm had revenue of $93.00 million during the quarter, compared to analysts’ expectations of $90.21 million. During the same period in the prior year, the company posted $0.27 EPS. The company’s revenue was up 32.8% compared to the same quarter last year. sell-side analysts forecast that Physicians Realty Trust will post 1.05 EPS for the current year.
In other Physicians Realty Trust news, insider Jeffrey Theiler bought 5,634 shares of the company’s stock in a transaction on Wednesday, November 8th. The shares were bought at an average cost of $17.76 per share, for a total transaction of $100,059.84. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Tommy G. Thompson bought 2,705 shares of the company’s stock in a transaction on Thursday, December 14th. The shares were acquired at an average price of $18.46 per share, for a total transaction of $49,934.30. Following the completion of the acquisition, the director now owns 49,339 shares in the company, valued at $910,797.94. The disclosure for this purchase can be found here. Corporate insiders own 0.51% of the company’s stock.
A number of institutional investors have recently modified their holdings of DOC. Schwab Charles Investment Management Inc. grew its holdings in Physicians Realty Trust by 8.3% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 630,471 shares of the real estate investment trust’s stock worth $12,698,000 after acquiring an additional 48,206 shares in the last quarter. JPMorgan Chase & Co. grew its holdings in Physicians Realty Trust by 7.0% during the 2nd quarter. JPMorgan Chase & Co. now owns 148,497 shares of the real estate investment trust’s stock worth $2,990,000 after acquiring an additional 9,660 shares in the last quarter. Alliancebernstein L.P. grew its holdings in Physicians Realty Trust by 3.7% during the 2nd quarter. Alliancebernstein L.P. now owns 288,816 shares of the real estate investment trust’s stock worth $5,817,000 after acquiring an additional 10,257 shares in the last quarter. Teachers Advisors LLC grew its holdings in Physicians Realty Trust by 10.5% during the 2nd quarter. Teachers Advisors LLC now owns 277,379 shares of the real estate investment trust’s stock worth $5,586,000 after acquiring an additional 26,452 shares in the last quarter. Finally, TIAA CREF Investment Management LLC grew its holdings in Physicians Realty Trust by 17.2% during the 2nd quarter. TIAA CREF Investment Management LLC now owns 970,892 shares of the real estate investment trust’s stock worth $19,554,000 after acquiring an additional 142,687 shares in the last quarter. Institutional investors own 93.41% of the company’s stock.
COPYRIGHT VIOLATION WARNING: This report was reported by Stock Observer and is the sole property of of Stock Observer. If you are reading this report on another website, it was illegally copied and reposted in violation of US & international trademark and copyright laws. The original version of this report can be accessed at https://www.thestockobserver.com/2018/01/22/physicians-realty-trust-doc-given-a-18-00-price-target-by-suntrust-banks-analysts.html.
Physicians Realty Trust Company Profile
Physicians Realty Trust (the Trust) is a real estate investment trust. Physicians Realty L.P. is the operating partnership of the Trust. The Trust and its operating partnership are engaged in acquiring, developing, owning and managing healthcare properties that are leased to physicians, hospitals and healthcare delivery systems.
Receive News & Ratings for Physicians Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Physicians Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.